SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2025-06-23 15:19
Tx date 2025-06-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$19,502
+3,213 vol
$6.07 each 		83,419
Filed 2025-06-10 10:49
Tx date 2025-06-06 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$49,995
+8,431 vol
$5.93 each 		80,206
Filed 2025-03-28 15:02
Tx date 2025-03-24 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$18,761
+3,026 vol
$6.20 each 		71,775
Filed 2024-12-20 11:00
Tx date 2024-12-17 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$18,756
+3,607 vol
$5.20 each 		68,749
Filed 2024-09-26 11:46
Tx date 2024-09-23 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$18,744
+3,083 vol
$6.08 each 		65,142
Filed 2024-07-01 16:24
Tx date 2024-06-30 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$18,223
+3,214 vol
$5.67 each 		62,059
Filed 2024-05-13 13:26
Tx date 2024-05-10 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$45,001
+7,576 vol
$5.94 each 		58,845
Filed 2024-04-08 16:39
Tx date 2024-04-04 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$36,340
+6,831 vol
$5.32 each 		51,269
Filed 2024-01-04 20:05
Tx date 2023-12-31 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,495
+3,371 vol
$5.19 each 		44,438
Filed 2023-09-21 14:07
Tx date 2023-09-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,498
+3,950 vol
$4.43 each 		41,067
Filed 2023-05-15 11:53
Tx date 2023-05-12 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$44,998
+9,259 vol
$4.86 each 		37,117
Filed 2023-04-04 21:57
Tx date 2023-03-31 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,498
+3,977 vol
$4.40 each 		27,858
Filed 2023-01-02 10:29
Tx date 2022-12-31 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,503
+3,379 vol
$5.18 each 		23,881
Filed 2022-10-03 10:27
Tx date 2022-09-30 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,496
+3,295 vol
$5.31 each 		20,502
Filed 2022-07-03 11:10
Tx date 2022-06-30 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$17,499
+3,277 vol
$5.34 each 		17,207
Filed 2022-05-16 10:06
Tx date 2022-05-13 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$44,996
+8,620 vol
$5.22 each 		13,930
Filed 2021-05-27 11:18
Tx date 2021-05-27 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,430
+2,000 vol
$5.21 each 		2,000
Filed 2021-05-27 11:15
Tx date 2019-05-07 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-24 15:38
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
56 - Grant of rights 		$30,001
+5,310 vol
$5.65 each 		5,310
Filed 2021-05-20 13:13
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other 		$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:30
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other 		$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 13:13
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other 		$30,001
+5,310 vol
$5.65 each 		5,310
Filed 2021-05-20 13:13
Tx date 2019-05-07 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:30
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other 		$30,001
+5,310 vol
$5.65 each 		5,310
Filed 2021-05-20 11:30
Tx date 2021-05-18 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
97 - Other 		$30,001
+5,310 vol
$5.65 each
Filed 2021-05-20 11:29
Tx date 2019-05-07 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2021-05-20 11:29
Tx date 2019-05-07 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
Filed 2020-07-03 16:11
Tx date 2020-07-01 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		40,000
Filed 2019-05-17 16:01
Tx date 2019-05-14 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+20,000 vol 		20,000
Filed 2019-05-17 15:58
Tx date 2019-05-07 		$GUD
Knight Therapeutics Inc. 		Tremblay, Michael Joseph
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report